930 related articles for article (PubMed ID: 12496748)
1. Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%.
Knibbe CA; Zuideveld KP; DeJongh J; Kuks PF; Aarts LP; Danhof M
Clin Pharmacol Ther; 2002 Dec; 72(6):670-84. PubMed ID: 12496748
[TBL] [Abstract][Full Text] [Related]
2. Long-term sedation with propofol 60 mg ml(-1) vs. propofol 10 mg(-1) ml in critically ill, mechanically ventilated patients.
Knibbe CA; Naber H; Aarts LP; Kuks PF; Danhof M
Acta Anaesthesiol Scand; 2004 Mar; 48(3):302-7. PubMed ID: 14982562
[TBL] [Abstract][Full Text] [Related]
3. Disease severity is a major determinant for the pharmacodynamics of propofol in critically ill patients.
Peeters MY; Bras LJ; DeJongh J; Wesselink RM; Aarts LP; Danhof M; Knibbe CA
Clin Pharmacol Ther; 2008 Mar; 83(3):443-51. PubMed ID: 17687274
[TBL] [Abstract][Full Text] [Related]
4. Clinical sedation scores as indicators of sedative and analgesic drug exposure in intensive care unit patients.
Masica AL; Girard TD; Wilkinson GR; Thomason JW; Truman Pun B; Nair UB; Light RW; Canonico AE; Dunn J; Pandharipande P; Shintani AK; Ely EW
Am J Geriatr Pharmacother; 2007 Sep; 5(3):218-31. PubMed ID: 17996661
[TBL] [Abstract][Full Text] [Related]
5. Optimal intravenous dosing strategies for sedatives and analgesics in the intensive care unit.
Barr J; Donner A
Crit Care Clin; 1995 Oct; 11(4):827-47. PubMed ID: 8535981
[TBL] [Abstract][Full Text] [Related]
6. Early phase pharmacokinetics but not pharmacodynamics are influenced by propofol infusion rate.
Masui K; Kira M; Kazama T; Hagihira S; Mortier EP; Struys MM
Anesthesiology; 2009 Oct; 111(4):805-17. PubMed ID: 19741485
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and effects of propofol 6% for short-term sedation in paediatric patients following cardiac surgery.
Knibbe CA; Melenhorst-de Jong G; Mestrom M; Rademaker CM; Reijnvaan AF; Zuideveld KP; Kuks PF; van Vught H; Danhof M
Br J Clin Pharmacol; 2002 Oct; 54(4):415-22. PubMed ID: 12392590
[TBL] [Abstract][Full Text] [Related]
8. Influence of formulation on propofol pharmacokinetics and pharmacodynamics in anesthetized patients.
Calvo R; Telletxea S; Leal N; Aguilera L; Suarez E; De La Fuente L; Martin-Suarez A; Lukas JC
Acta Anaesthesiol Scand; 2004 Sep; 48(8):1038-48. PubMed ID: 15315624
[TBL] [Abstract][Full Text] [Related]
9. Bispectral index as a guide for titration of propofol during procedural sedation among children.
Powers KS; Nazarian EB; Tapyrik SA; Kohli SM; Yin H; van der Jagt EW; Sullivan JS; Rubenstein JS
Pediatrics; 2005 Jun; 115(6):1666-74. PubMed ID: 15930231
[TBL] [Abstract][Full Text] [Related]
10. Mixed-effects modeling of the influence of midazolam on propofol pharmacokinetics.
Vuyk J; Lichtenbelt BJ; Olofsen E; van Kleef JW; Dahan A
Anesth Analg; 2009 May; 108(5):1522-30. PubMed ID: 19372331
[TBL] [Abstract][Full Text] [Related]
11. Propofol reduces the distribution and clearance of midazolam.
Lichtenbelt BJ; Olofsen E; Dahan A; van Kleef JW; Struys MM; Vuyk J
Anesth Analg; 2010 Jun; 110(6):1597-606. PubMed ID: 20435936
[TBL] [Abstract][Full Text] [Related]
12. Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients.
Swart EL; Zuideveld KP; de Jongh J; Danhof M; Thijs LG; Strack van Schijndel RM
Br J Clin Pharmacol; 2004 Feb; 57(2):135-45. PubMed ID: 14748812
[TBL] [Abstract][Full Text] [Related]
13. Altered dose-to-effect of propofol due to pharmacokinetics in rats with experimental diabetes mellitus.
Leal N; Calvo R; Agrad FZ; Lukas JC; de la Fuente L; Suarez E
J Pharm Pharmacol; 2005 Mar; 57(3):317-25. PubMed ID: 15807987
[TBL] [Abstract][Full Text] [Related]
14. [The effects of long-term sedation on intestinal function].
Zielmann S; Grote R
Anaesthesist; 1995 Dec; 44 Suppl 3():S549-58. PubMed ID: 8592966
[TBL] [Abstract][Full Text] [Related]
15. [Propofol versus midazolam. Long-term sedation in the intensive care unit].
Beyer R; Seyde WC
Anaesthesist; 1992 Jun; 41(6):335-41. PubMed ID: 1636917
[TBL] [Abstract][Full Text] [Related]
16. Effect site concentration during propofol TCI sedation: a comparison of sedation score with two pharmacokinetic models.
Barakat AR; Sutcliffe N; Schwab M
Anaesthesia; 2007 Jul; 62(7):661-6. PubMed ID: 17567340
[TBL] [Abstract][Full Text] [Related]
17. Propofol dosing regimens for ICU sedation based upon an integrated pharmacokinetic-pharmacodynamic model.
Barr J; Egan TD; Sandoval NF; Zomorodi K; Cohane C; Gambus PL; Shafer SL
Anesthesiology; 2001 Aug; 95(2):324-33. PubMed ID: 11506101
[TBL] [Abstract][Full Text] [Related]
18. The relationship between sedative infusion requirements and permissive hypercapnia in critically ill, mechanically ventilated patients.
Vinayak AG; Gehlbach B; Pohlman AS; Hall JB; Kress JP
Crit Care Med; 2006 Jun; 34(6):1668-73. PubMed ID: 16625127
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and the pharmacodynamic action of midazolam in young and elderly patients undergoing tooth extraction.
Platten HP; Schweizer E; Dilger K; Mikus G; Klotz U
Clin Pharmacol Ther; 1998 May; 63(5):552-60. PubMed ID: 9630828
[TBL] [Abstract][Full Text] [Related]
20. Pharmacoeconomic modeling of lorazepam, midazolam, and propofol for continuous sedation in critically ill patients.
MacLaren R; Sullivan PW
Pharmacotherapy; 2005 Oct; 25(10):1319-28. PubMed ID: 16185175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
